AI, vaccine distrust, and the future of healthcare: Novartis CEO

AI, vaccine distrust, and the future of healt...

Up next

How Amazon is transforming your Whole Foods run: CEO

Yahoo Finance Executive Editor Brian Sozzi sits down with Amazon Worldwide Grocery Stores Vice President and Whole Foods Market CEO Jason Buechel to discuss how Amazon's latest tech is reshaping the grocery giant. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Why you need an AI agent workforce today: Open Machine CEO

Open Machine CEO Allie K. Miller talks to Yahoo Finance Executive Editor Brian Sozzi about the rapid evolution of artificial intelligence and the critical shift from standard chatbots to autonomous AI agents. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Recommended Episodes

Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
In Good Company with Nicolai Tangen

Can AI help us find cures for diseases we've never been able to treat? Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation. They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, ...  Show more

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
In Good Company with Nicolai Tangen

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...

  Show more

Vas Narasimhan
The David Rubenstein Show

Novartis CEO Vas Narasimhan talks about transforming the pharmaceutical giant into an innovative medicines company. He speaks on "The David Rubenstein Show: Peer-to-Peer Conversations". This interview was recorded February 15 in New York.See omnystudio.com/listener for privacy in ...  Show more

Big Pharma Breakout… And A Billionaire Boycott On Netflix 10/1/25
CNBC's "Fast Money"

Pharma stocks breaking out, as President Trump inks a drug pricing deal. What it means for the group, and how the broader health care sector is breathing a sigh of relief. Plus Elon Musk and some bingeing backlash. Why the billionaire is calling for customers to cancel their s ...

  Show more